A detailed history of Axq Capital, LP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Axq Capital, LP holds 35,391 shares of MRVI stock, worth $78,214. This represents 0.03% of its overall portfolio holdings.

Number of Shares
35,391
Holding current value
$78,214
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$2.21 - $6.13 $78,214 - $216,946
35,391 New
35,391 $78.2 Million
Q2 2024

Aug 13, 2024

SELL
$6.87 - $11.34 $89,948 - $148,474
-13,093 Reduced 25.63%
37,982 $272 Million
Q1 2024

May 14, 2024

SELL
$5.11 - $8.76 $18,012 - $30,879
-3,525 Reduced 6.46%
51,075 $443 Million
Q4 2023

Feb 13, 2024

BUY
$4.7 - $9.87 $256,620 - $538,902
54,600 New
54,600 $358 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $291M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.